MINI-REVIEWS IN MEDICINAL CHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2023-01-30 ms7000001159925877 来自四川省

投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-12-28 Mia

如何判断两种药物之间是协同作用还是相加作用？

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

如果文章发表了未提供ORCIDID如何添加？

29 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2015-06-17 miaomiaomi

审稿速度:6.0 | 投稿命中率:50.0
经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。

424 0

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2013-07-01 gubing035

这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？

438 0

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2012-12-09 ms6179535627532318

大家好：
我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！

93 0

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2012-12-09 ms3908193925310106

现在每年14期，不是季刊吧

123 0

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-11-19 wangxiaobao

审稿速度:6.0 | 投稿命中率:75.0
经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。

506 0

[GetPortalCommentsPageByObjectIdResponse(id=2112121, encodeId=47a52112121fe, content=投了一篇文章，已经确认发表，编辑很快，对文章的建议很好，审稿周期稍长，但是命中率很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5f76543920, createdName=ms7000001159925877, createdTime=Mon Jan 30 15:12:39 CST 2023, time=2023-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1095147, encodeId=3d25109514edf, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095148, encodeId=a04c109514888, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512591, encodeId=fd97512591ac, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：非常不错的杂志，就是审稿时间挺长的，编辑很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08a61628469, createdName=miaomiaomi, createdTime=Wed Jun 17 14:39:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497044, encodeId=8b2549e0446e, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822949, encodeId=a3f18229496e, content=大家好： 我投了一篇小综述，已接受了，但是编辑部回信说the galley proofs have been dispatched to you for your review ，可是我查了邮件就没有附件资料，也没有有关清样的资料，请问这个杂志是通过邮件发清样还是通过邮局邮寄清样，请投过的有经验的朋友能给予指导，谢谢！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aba65413994, createdName=ms6179535627532318, createdTime=Sun Dec 09 12:43:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=822948, encodeId=ddfc82294842, content=现在每年14期，不是季刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Sun Dec 09 10:42:00 CST 2012, time=2012-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485498, encodeId=d32a485498dd, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：该杂志审稿速度较慢，但是命中率还算可以。不过写的综述要具有新颖性，至少是以前没有发表过过的内容。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a75e50454, createdName=wangxiaobao, createdTime=Sat Nov 19 22:02:00 CST 2011, time=2011-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=475836, encodeId=81f44e5836bc, content=目前正准备投稿，有经验了再大家一起分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=534, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77c924775, createdName=kelloy, createdTime=Tue Jun 28 10:12:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-06-28 kelloy

目前正准备投稿，有经验了再大家一起分享

534 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务